ARCHIVES

Two former Bristol-Myers Squibb executives were indicted as the company agreed to pay $300 million to investors.

This article is from The Cancer Letter archive.

Vol. 31 No. 24 | June 17, 2005

Download PDF Visit The Full Archive

Related Articles

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

Trials Suspended At Oklahoma Over Study Of Cancer Vaccine.

July 14, 2000

Racker Withdraws Some Claims Made In Science Article, Says Data Are “No Question A Mess”

September 11, 1981

Hollings Resolution Recognizes 20th Year Of National Cancer Act

May 3, 1991

NCI Starts $2 Million Study On Cancer Patient Job Discrimination

January 17, 1975

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000